Brand Name | Status | Last Update |
---|---|---|
amlodipine and olmesartan medoxomil | ANDA | 2025-05-30 |
amlodipine and olmesartan medoxomil amlodipine and olmesartan medoxomil | ANDA | 2025-03-26 |
amlodipine besylate and olmesartan medoxomil | New Drug Application | 2024-06-03 |
azor | New Drug Application | 2023-07-12 |
benicar | New Drug Application | 2023-07-12 |
benicar hct | New Drug Application | 2023-07-12 |
olmesartan medoxomil | ANDA | 2025-06-11 |
olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | ANDA | 2024-11-06 |
olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide | ANDA | 2025-06-30 |
olmesartan medoxomil and hydrochlorothiazide | ANDA | 2025-07-14 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 1 | 1 | 11 | 13 | 2 | 27 |
Essential hypertension | D000075222 | — | I10 | — | — | 7 | 2 | 1 | 10 |
Kidney diseases | D007674 | EFO_0003086 | N08 | — | 1 | 1 | 1 | — | 3 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | 1 | 1 | — | 2 |
Chronic renal insufficiency | D051436 | — | N18 | — | — | — | 1 | — | 1 |
Albuminuria | D000419 | EFO_0004285 | R80.9 | — | — | — | 1 | — | 1 |
Insulin resistance | D007333 | EFO_0002614 | E88.819 | — | — | — | 1 | — | 1 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | — | 1 | — | 1 |
Overweight | D050177 | — | E66.3 | — | — | — | 1 | — | 1 |
Healthy volunteers/patients | — | — | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetic nephropathies | D003928 | EFO_0000401 | — | — | 1 | 1 | — | — | 2 |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | 1 | — | — | 1 |
Proteinuria | D011507 | — | R80 | — | — | 1 | — | — | 1 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | 1 | — | — | 1 |
Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | 1 | — | — | 1 |
Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | 1 | — | — | 1 |
Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Glomerulonephritis | D005921 | — | N05 | — | 1 | — | — | — | 1 |
Chronic disease | D002908 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Exercise | D015444 | EFO_0000483 | — | — | — | — | — | 1 | 1 |
Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | — | — | 1 | 1 |
Prediabetic state | D011236 | EFO_1001121 | R73.03 | — | — | — | — | 1 | 1 |
Glucose intolerance | D018149 | HP_0000833 | R73.03 | — | — | — | — | 1 | 1 |
Drug common name | Olmesartan |
INN | olmesartan |
Description | Olmesartan medoxomil is a member of biphenyls. |
Classification | Small molecule |
Drug class | angiotensin II receptor antagonists |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1 |
PDB | — |
CAS-ID | 144689-24-7 |
RxCUI | — |
ChEMBL ID | CHEMBL1516 |
ChEBI ID | 48416 |
PubChem CID | 130881 |
DrugBank | DB00275 |
UNII ID | 8W1IQP3U10 (ChemIDplus, GSRS) |